SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

FOLCH, Cinta  and  GRUPO REDAN et al. Perfil de los usuarios de drogas por vía parenteral que mantienen conductas de riesgo relacionadas con la inyección en Cataluña. Gac Sanit [online]. 2012, vol.26, n.1, pp.37-44. ISSN 0213-9111.  http://dx.doi.org/10.1590/S0213-91112012000100007.

    1. De la Fuente L, Brugal MT, Domingo-Salvany A, et al. Más de treinta años de drogas ilegales en España: una amarga historia con algunos consejos para el futuro. Rev Esp Salud Pública. 2006; 80:505-20. [ Links ]

    2. Registros autonómicos de casos de sida. Centro Nacional de Epidemiología. Vigilancia epidemiológica del sida en España. Registro nacional de casos de sida. Actualización a 30 de junio de 2010. Madrid: Dirección General de Salud Pública y Sanidad Exterior; Instituto de Salud Carlos III; 2010. (Consultado el 7/12/2010.) Disponible en: http://www.isciii.es/htdocs/centros/epidemiologia/pdf/SPNS_Informe_semestral.pdf. [ Links ]

    3. Instituto de Salud Carlos III. Dirección General de Salud Pública y Sanidad Exterior. Vigilancia epidemiológica del VIH en España. Nuevos diagnósticos de VIH en España. Periodo 2003-2009. Actualización: 30 de junio de 2010. [ Links ]

    4. Plan multisectorial frente a la infección por VIH y el sida. España 2008-2012. Ministerio de Sanidad, Madrid, 2008. 2010 (Consultado el 7/7/2011.) Disponible en: http://www.msc.es/ciudadanos/enfLesiones/enfTransmisibles/sida/docs/PMS200812.pdf. [ Links ]

    5. Correlation Network. Hepatitis C transmission and injecting drug use: harm reduction responses. Vilnius: Eurasian Harm Reduction Network; 2010. [ Links ]

    6. Muga R, Sanvisens A, Bolao F, et al. Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001. Drug Alcohol Depend. 2006; 82(Suppl 1):S29-33. [ Links ]

    7. Huntington S, Folch C, González V, et al. Prevalencia del VIH, hepatitis C y factores asociados en usuarios de drogas por vía parenteral seleccionados en Cataluña. Enferm Infecc Microbiol Clin. 2010; 28:236-8. [ Links ]

    8. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2009: the state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union; 2009. (Consultado el 5/2/2010.) Disponible en: http://www.emcdda.europa.eu/publications/annual-report/2009. [ Links ]

    9. Vallejo F, Toro C, Brugal MT, et al. Muy alta incidencia de VIH y VHC en jóvenes consumidores de heroína. En: XXIV Reunión Científica Anual de la Sociedad Española de Epidemiología. Logroño. 2006. Comunicación oral. [ Links ]

    10. De la Fuente L, Bravo MJ, Toro C, et al. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes. J Epidemiol Community Health. 2006; 60:537-42. [ Links ]

    11. Barrio G, De La Fuente L, Toro C, et al. Prevalence of HIV infection among young adult injecting and non-injecting heroin users in Spain in the era of harm reduction programmes: gender differences and other related factors. Epidemiol Infect. 2007; 135:592-603. [ Links ]

    12. Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya. Sistema integrat de vigilància epidemiològica de la SIDA/VIH/ITS a Catalunya (SIVES). Barcelona: Generalitat de Catalunya, Departament de Salut; 2008. [ Links ]

    13. Wodak A, Cooney A. Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006; 41:777-813. [ Links ]

    14. Cook C, Kanaef N. The global state of harm reduction 2008. London: International Harm Reduction Association; 2008. [ Links ]

    15. Secretaría del Plan Nacional sobre el Sida. ICAP 2008. Informe del cuestionario de actividades de prevención del VIH en las comunidades autónomas. Año 2008. Madrid: Ministerio de Sanidad y Política Social, Dirección General de Salud Pública y Sanidad Exterior; 2008. (Consultado el 7/12/2010.) Disponible en: http://www.msps.es/ciudadanos/enfLesiones/enfTransmisibles/sida/docs/ICAP2008/ICAP2008.pdf. [ Links ]

    16. Thorpe LE, Ouellet LJ, Hershow R, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002; 155:645-53. [ Links ]

    17. Bravo MJ, Royuela L, Barrio G, et al. Prevalencia de prácticas indirectas de compartir material para inyectarse drogas en Galicia, Madrid, Sevilla y Valencia. Gac Sanit. 2004; 18:472-8. [ Links ]

    18. Folch C, Meroño M, Casabona J. Factores asociados a la práctica de compartir jeringuillas usadas entre usuarios de droga por vía parenteral reclutados en la calle. Med Clin (Barc). 2006; 127:526-32. [ Links ]

    19. Brugal MT, Pulido J, Toro C, et al. Injecting, sexual risk behaviors and HIV infection in young cocaine and heroin users in Spain. Eur Addict Res. 2009; 15:171-8. [ Links ]

    20. Bravo MJ, Royuela L, De la Fuente L, et al. Use of supervised injection facilities and injection risk behaviours among young drug injectors. Addiction. 2009; 104:614-9. [ Links ]

    21. World Health Organization. Multy-city study on drug injecting and risk of HIV infection. En: Programme on substance abuse - final report. Geneva: WHO; 1994. [ Links ]

    22. Chohan BH, Lavreys L, Mandaliya KN, et al. Validation of a modified commercial enzyme-linked immunoassay for detection of human immunodeficiency virus type 1 immunoglobulin G antibodies in saliva. Clin Diagn Lab Immunol. 2001; 8:346-8. [ Links ]

    23. Judd A, Parry J, Hickman M, et al. Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol. 2003; 71:49-55. [ Links ]

    24. Strike C, Buchman DZ, Callaghan RC, et al. Giving away used injection equipment: missed prevention message?. Harm Reduct J. 2010; 7:2. [ Links ]

    25. Shapshak P, Fujimura RK, Page JB, et al. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. Drug Alcohol Depend. 2000; 58:153-7. [ Links ]

    26. Shah SM, Shapshak P, Rivers JE, et al. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 11:301-6. [ Links ]

    27. Rodríguez-Arenas MA, Zunzunegui MV, Friedman SR, et al. Sharing syringes in Madrid. A social phenomenon. Eur J Public Health. 1996; 1:11-4. [ Links ]

    28. Bravo MJ, Royuela L, Barrio G, et al. Acceso a jeringas estériles entre los jóvenes de Madrid y Barcelona que se inyectan drogas y su asociación con las prácticas de riesgo. Gac Sanit. 2008; 22:128-32. [ Links ]

    29. Tyndall MW, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003; 17:887-93. [ Links ]

    30. Koester S, Booth RE, Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1996; 12:202-7. [ Links ]

    31. Rosengard C, Anderson B, Stein MD. Intravenous drug users' HIV-risk behaviors with primary/other partners. Am J Drug Alcohol Abuse. 2004; 30:225-36. [ Links ]

    32. Gyarmathy VA, Li N, Tobin KE, et al. Injecting equipment sharing in Russian drug injecting dyads. AIDS Behav. 2010; 14:141-51. [ Links ]

    33. Ouellet L, Huo D, Bailey SL. HIV risk practices among needle exchange users and nonusers in Chicago. J Acquir Immune Defic Syndr. 2004; 37:1187-96. [ Links ]

    34. Des Jarlais DC, Perlis T, Arasteh K, et al. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001. J Acquir Immune Defic Syndr. 2004; 35:158-66. [ Links ]

    35. Magis-Rodríguez C, Brouwer KC, Morales S, et al. HIV prevalence and correlates of receptive needle sharing among injection drug users in the Mexican-U.S. border city of Tijuana. J Psychoactive Drugs. 2005; 37:333-9. [ Links ]

    36. Rafiey H, Narenjiha H, Shirinbayan P, et al. Needle syringe sharing among Iranian drug injectors. Harm Reduct J. 2009; 6:21. [ Links ]

    37. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001; 345:41-52. [ Links ]